FDA has approved the first drug for thymidine kinase 2 deficiency treatment

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

FDA has approved the first drug for thymidine kinase 2 deficiency treatment. Pediatric pharmacology. 2025;22(5):632. (In Russ.)

Views PDF (Rus): 14

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?